Education
About Us
Working with TipRanks
Follow Us
Q-linea AB (DE:3F8)
FRANKFURT:3F8
3F8 Stock Chart & Stats
Day’s Range― - ―
52-Week Range<€0.01 - €0.05
Previous CloseN/A
Volume9.40K
Average Volume (3M)3.36K
Market Cap
€17.46M
Enterprise Value€426.06M
Total Cash (Recent Filing)kr25.66M
Total Debt (Recent Filing)kr151.21M
Price to Earnings (P/E)―
Beta101.96
Next Earnings
Jul 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding4,448,288,000
10 Day Avg. Volume2,517
30 Day Avg. Volume3,360
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)11.37
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Q-linea AB News
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
3F8 FAQ
What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was <€0.01 and its highest was €0.05 in the past 12 months.
What is Q-linea AB’s market cap?
Q-linea AB’s market cap is €17.46M.
When is Q-linea AB’s upcoming earnings report date?
Q-linea AB’s upcoming earnings report date is Jul 10, 2025 which is in 82 days.
How were Q-linea AB’s earnings last quarter?
Q-linea AB released its earnings results on Apr 14, 2025. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is Q-linea AB overvalued?
According to Wall Street analysts Q-linea AB’s price is currently Overvalued.
Does Q-linea AB pay dividends?
Q-linea AB does not currently pay dividends.
What is Q-linea AB’s EPS estimate?
Q-linea AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q-linea AB have?
Q-linea AB has 4,448,288,000 shares outstanding.
What happened to Q-linea AB’s price movement after its last earnings report?
Q-linea AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Q-linea AB?
Currently, no hedge funds are holding shares in DE:3F8
---
Company Description
Q-linea AB
Q-linea AB is a company that develops solutions for improved infectious disease diagnostics. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
---
Technical Analysis
SciBase Holding AB
―
Clinical Laserthermia Systems AB Class B
―
SpectraCure AB
―
Luxbright AB
―
Acarix AB
―
---